Cargando…
Update on management of seminoma
Testicular germ cell tumors and, in particular, seminomas are exquisitely radiation and chemotherapy-sensitive and most presentations are highly curable. In recent years the management focus has been on reducing late sequelae of treatment. For Stage I disease surveillance and adjuvant carboplatin, c...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878445/ https://www.ncbi.nlm.nih.gov/pubmed/20535292 http://dx.doi.org/10.4103/0970-1591.60451 |
| _version_ | 1782181871398944768 |
|---|---|
| author | Alexander, Emma J. White, Ingrid M. Horwich, Alan |
| author_facet | Alexander, Emma J. White, Ingrid M. Horwich, Alan |
| author_sort | Alexander, Emma J. |
| collection | PubMed |
| description | Testicular germ cell tumors and, in particular, seminomas are exquisitely radiation and chemotherapy-sensitive and most presentations are highly curable. In recent years the management focus has been on reducing late sequelae of treatment. For Stage I disease surveillance and adjuvant carboplatin, chemotherapy has become an option. The efficacy of combination chemotherapy has been established for advanced metastatic disease. Through a review of the available literature this article outlines the recent changes in the management of seminoma. |
| format | Text |
| id | pubmed-2878445 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | Medknow Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-28784452010-06-09 Update on management of seminoma Alexander, Emma J. White, Ingrid M. Horwich, Alan Indian J Urol Symposium Testicular germ cell tumors and, in particular, seminomas are exquisitely radiation and chemotherapy-sensitive and most presentations are highly curable. In recent years the management focus has been on reducing late sequelae of treatment. For Stage I disease surveillance and adjuvant carboplatin, chemotherapy has become an option. The efficacy of combination chemotherapy has been established for advanced metastatic disease. Through a review of the available literature this article outlines the recent changes in the management of seminoma. Medknow Publications 2010 /pmc/articles/PMC2878445/ /pubmed/20535292 http://dx.doi.org/10.4103/0970-1591.60451 Text en © Indian Journal of Urology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Symposium Alexander, Emma J. White, Ingrid M. Horwich, Alan Update on management of seminoma |
| title | Update on management of seminoma |
| title_full | Update on management of seminoma |
| title_fullStr | Update on management of seminoma |
| title_full_unstemmed | Update on management of seminoma |
| title_short | Update on management of seminoma |
| title_sort | update on management of seminoma |
| topic | Symposium |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878445/ https://www.ncbi.nlm.nih.gov/pubmed/20535292 http://dx.doi.org/10.4103/0970-1591.60451 |
| work_keys_str_mv | AT alexanderemmaj updateonmanagementofseminoma AT whiteingridm updateonmanagementofseminoma AT horwichalan updateonmanagementofseminoma |